4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-14-002174
$IRDCIK 0001228627operating
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 7:25 PM ET
Size
6.7 KB
Accession
0001140361-14-002174
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Stock Option (right to purchase)
2014-01-12+350,000→ 350,000 totalExercise: $1.14Exp: 2024-01-12→ Common Stock (350,000 underlying)
Holdings
- 1,200,000
Stock Option (right to purchase)
Exercise: $0.37From: 2013-02-04Exp: 2023-02-04→ Common Stock (1,200,000 underlying)
Footnotes (1)
- [F1]Options will vest and be exercisable based on the following schedule: 105,000 on January 12, 2015, 105,000 on January 12, 2016, and 140,000 on January 12, 2017.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 7:25 PM ET
- Size
- 6.7 KB